Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
BlackRock Inc.
> NTLA
Date | Name | Ticker | Shares | Change | Value | Change | Price |
06/30/2023 | Intellia Therapeutics, Inc. | NTLA | 8,054,963 | 706,344 | 328,481,402,000 | 54,598,360,000 | $40,780.00 |
03/31/2023 | Intellia Therapeutics, Inc. | NTLA | 7,348,619 | 1,220,479 | 273,883,042,000 | 273,540,112,000 | $37,270.00 |
09/30/2022 | Intellia Therapeutics, Inc. | NTLA | 6,128,140 | 240,741 | 342,930,000 | 38,199,000 | $55.96 |
06/30/2022 | Intellia Therapeutics, Inc. | NTLA | 5,887,399 | 285,660 | 304,731,000 | -102,348,000 | $51.76 |
03/31/2022 | Intellia Therapeutics, Inc. | NTLA | 5,601,739 | -18,637 | 407,079,000 | -257,474,000 | $72.67 |
12/31/2021 | Intellia Therapeutics, Inc. | NTLA | 5,620,376 | 89,381 | 664,553,000 | -77,432,000 | $118.24 |
09/30/2021 | Intellia Therapeutics, Inc. | NTLA | 5,530,995 | 565,430 | 741,985,000 | -61,989,000 | $134.15 |
06/30/2021 | Intellia Therapeutics, Inc. | NTLA | 4,965,565 | -306,061 | 803,974,000 | 380,900,000 | $161.91 |
03/31/2021 | Intellia Therapeutics, Inc. | NTLA | 5,271,626 | 218,781 | 423,074,000 | 148,198,000 | $80.25 |
12/31/2020 | Intellia Therapeutics, Inc. | NTLA | 5,052,845 | -592,164 | 274,876,000 | 162,652,000 | $54.40 |
09/30/2020 | Intellia Therapeutics, Inc. | NTLA | 5,645,009 | 594,183 | 112,224,000 | 6,056,000 | $19.88 |
06/30/2020 | Intellia Therapeutics, Inc. | NTLA | 5,050,826 | 1,258,528 | 106,168,000 | 59,789,000 | $21.02 |
03/31/2020 | Intellia Therapeutics, Inc. | NTLA | 3,792,298 | 147,068 | 46,379,000 | -7,097,000 | $12.23 |
12/31/2019 | Intellia Therapeutics, Inc. | NTLA | 3,645,230 | 64,632 | 53,476,000 | 5,676,000 | $14.67 |
09/30/2019 | Intellia Therapeutics, Inc. | NTLA | 3,580,598 | 190,331 | 47,800,000 | 47,744,501 | $13.35 |
06/30/2019 | Intellia Therapeutics, Inc. | NTLA | 3,390,267 | 208,548 | 55,499 | -54,287,501 | $0.02 |
03/31/2019 | Intellia Therapeutics, Inc. | NTLA | 3,181,719 | 312,981 | 54,343,000 | 15,185,000 | $17.08 |
12/31/2018 | Intellia Therapeutics, Inc. | NTLA | 2,868,738 | 124,341 | 39,158,000 | -39,387,000 | $13.65 |
09/30/2018 | Intellia Therapeutics, Inc. | NTLA | 2,744,397 | 188,098 | 78,545,000 | 8,605,000 | $28.62 |
06/30/2018 | Intellia Therapeutics, Inc. | NTLA | 2,556,299 | 833,337 | 69,940,000 | 33,602,000 | $27.36 |
03/31/2018 | Intellia Therapeutics, Inc. | NTLA | 1,722,962 | 12,015 | 36,338,000 | 3,453,000 | $21.09 |
12/31/2017 | Intellia Therapeutics, Inc. | NTLA | 1,710,947 | 31,662 | 32,885,000 | -8,845,000 | $19.22 |
09/30/2017 | Intellia Therapeutics, Inc. | NTLA | 1,679,285 | 3,949 | 41,730,000 | 14,924,000 | $24.85 |
06/30/2017 | Intellia Therapeutics, Inc. | NTLA | 1,675,336 | 731,992 | 26,806,000 | 13,513,000 | $16.00 |
03/31/2017 | Intellia Therapeutics, Inc. | NTLA | 943,344 | 942,943 | 13,293,000 | 13,288,000 | $14.09 |
12/31/2016 | Intellia Therapeutics, Inc. | NTLA | 401 | 0 | 5,000 | -2,000 | $12.47 |
09/30/2016 | Intellia Therapeutics, Inc. | NTLA | 401 | 401 | 7,000 | 7,000 | $17.46 |
06/30/2016 | Intellia Therapeutics, Inc. | NTLA | 2,464 | 2,464 | 53,000 | 53,000 | $21.51 |
<< Prev Next >> |
|